Thomas Ebensen

Title: Thomas Ebensen - Innovator in Immune Response Research

Introduction

Thomas Ebensen is an accomplished inventor based in Langenhagen, Germany. He is currently affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH. Although he has not yet been granted any patents, his work focuses on significant advancements in immune response research.

Latest Patent Applications

Thomas Ebensen has submitted several notable patent applications. One of his latest applications is titled "Phytosphingosine Derivatives as Adjuvants in Immune Stimulation." This application discusses phytosphingosine derivatives that are suitable as adjuvants in immune stimulation, along with pharmaceutical compositions that include these compounds. The medical use of these compounds and compositions aims to provide therapeutic benefits in stimulating immune responses in subjects, including their application in treating diseases and vaccinating individuals.

Another significant application is "New Use of Cyclic Dinucleotides." This invention relates to cyclic dinucleotide compounds, particularly c-di AMP, which can induce or promote immune responses in neonates or infants. The application emphasizes the therapeutic and prophylactic use of these compounds in vaccinations, especially for vulnerable populations such as unborn children and infants.

Conclusion

Thomas Ebensen is making strides in the field of immune response research through his innovative patent applications. His contributions have the potential to enhance therapeutic methods and improve health outcomes for various populations.